Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.5M
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
58.3M
-
Shares change
-
+320K
-
Total reported value, excl. options
-
$2.62B
-
Value change
-
+$35.4M
-
Put/Call ratio
-
0.75
-
Number of buys
-
92
-
Number of sells
-
-80
-
Price
-
$45.00
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2019
218 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2019.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.3M shares
of 79.5M outstanding shares and own 73.31% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.07M shares), BlackRock Inc. (4.5M shares), FRANKLIN RESOURCES INC (4.19M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.87M shares), RTW INVESTMENTS, LP (3.14M shares), Point72 Asset Management, L.P. (2.65M shares), FMR LLC (2.37M shares), STATE STREET CORP (2.31M shares), ORBIMED ADVISORS LLC (2.09M shares), and GREAT POINT PARTNERS LLC (1.97M shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.